Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
4D Pharma Plc ADR
(NQ:
LBPS
)
N/A
UNCHANGED
Last Price
Updated: 9:38 AM EDT, Jun 24, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.610 (1)
Ask (Size)
1.660 (2)
Prev. Close
1.650
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq
June 28, 2022
From
4D pharma plc
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022
June 27, 2022
Upgrades
Via
Benzinga
Performance
More News
Read More
Update on Suspension of Trading
June 24, 2022
From
4D pharma
Via
Business Wire
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
June 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 22, 2022
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
June 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 22, 2022
Via
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Via
Benzinga
4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 26, 2022
From
4D pharma plc
Via
Business Wire
4D pharma to Present at the H.C. Wainwright Global Investment Conference
May 19, 2022
From
4D pharma
Via
Business Wire
4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference
May 17, 2022
From
4D pharma
Via
Business Wire
24 Stocks Moving in Thursday's Pre-Market Session
May 05, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 21, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 19, 2022
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 14, 2022
Via
InvestorPlace
55 Biggest Movers From Friday
April 04, 2022
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
April 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 01, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 01, 2022
Via
InvestorPlace
21 Stocks Moving in Friday's Pre-Market Session
April 01, 2022
Via
Benzinga
4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022
March 31, 2022
From
4D pharma plc
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 29, 2022
Via
Benzinga
Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer
March 24, 2022
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
